V. Westeel

Etoposide Plus Cisplatin With or Without the Combination of 4'-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study

Jean-Louis Pujol, Jean Pierre Daurès, Aart Brutel de la Rivière et al. · JNCI Journal of the National Cancer Institute · 2001 · 173 citations

Maintenance with either gemcitabine or erlotinib versus observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy in advanced NSCLC: IFCT-GFPC 0502 phase III study.

M. Pérol, C. Chouaïd, B. Milleron et al. · Journal of Clinical Oncology · 2010 · 93 citations

Advanced Nsclc, Oncology, Cancer Management +15

Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC).

Élisabeth Quoix, J.P. Oster, V. Westeel et al. · Journal of Clinical Oncology · 2010 · 65 citations

Weekly Paclitaxel, Pharmacotherapy, Overall Survival +18

New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen.

V. Westeel, Nevin Murray, Karen A. Gelmon et al. · Journal of Clinical Oncology · 1998 · 63 citations

Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer.

V. Westeel, B. Milleron, Élisabeth Quoix et al. · Journal of Clinical Oncology · 2010 · 23 citations

Surgical Oncology, Cancer Management, Multimodality +18